[{"Assets_0_Q2_USD":134666000.0,"CommonStockSharesOutstanding_0_Q2_shares":22219843.0,"NetIncomeLoss_1_Q2_USD":-13639000.0,"NetIncomeLoss_2_Q2_USD":-26610000.0,"StockholdersEquity_0_Q2_USD":109337000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170810"}]